These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35619963)

  • 1. Prognostic Roles of Glucose to Lymphocyte Ratio and Modified Glasgow Prognosis Score in Patients With Non-small Cell Lung Cancer.
    Yang M; Zhang Q; Ge YZ; Tang M; Hu CL; Wang ZW; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Zhang KP; Li QQ; Li XR; Liu XY; Lin SQ; Shi HP
    Front Nutr; 2022; 9():871301. PubMed ID: 35619963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
    Yang M; Lin SQ; Liu XY; Tang M; Hu CL; Wang ZW; Zhang Q; Zhang X; Song MM; Ruan GT; Zhang XW; Liu T; Xie HL; Zhang HY; Liu CA; Zhang KP; Li QQ; Li XR; Ge YZ; Liu YY; Chen Y; Zheng X; Shi HP
    Front Immunol; 2023; 14():1131496. PubMed ID: 37063910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of Glucose to Lymphocyte Ratio (GLR) as a Prognostic Marker for Patients With Pancreatic Cancer.
    Zhong A; Cheng CS; Kai J; Lu R; Guo L
    Front Oncol; 2020; 10():520330. PubMed ID: 33117673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose to lymphocyte ratio predicts prognoses in patients with colorectal cancer.
    Yang M; Zhang Q; Ge Y; Tang M; Zhang X; Song M; Ruan G; Zhang X; Zhang K; Shi H
    Asia Pac J Clin Oncol; 2023 Aug; 19(4):542-548. PubMed ID: 36479824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.
    Minami S; Ihara S; Kim SH; Yamamoto S; Komuta K
    World J Oncol; 2018 Feb; 9(1):13-20. PubMed ID: 29581811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection.
    Fu Y; Yang X; Liang H; Wu X
    Cancer Manag Res; 2019; 11():5091-5100. PubMed ID: 31213920
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination of handgrip strength and high-sensitivity modified Glasgow prognostic score predicts survival outcomes in patients with colon cancer.
    Shi Y; Sun Y; Shen X; Yang Z; Xu B; Bao C
    Front Nutr; 2024; 11():1421560. PubMed ID: 39010859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients.
    Winther-Larsen A; Aggerholm-Pedersen N; Sandfeld-Paulsen B
    BMC Cancer; 2022 Jan; 22(1):63. PubMed ID: 35027001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy.
    Minami S; Ihara S; Komuta K
    J Clin Med Res; 2018 Aug; 10(8):657-664. PubMed ID: 29977424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Dynamic Nomogram Integrated with Inflammation-Based Factors for Non-Small Cell Lung Cancer Patients with Chronic Hepatitis B Viral Infection.
    Chen S; Li X; Lv H; Wen X; Ding Q; Xue N; Su H; Chen H
    Int J Biol Sci; 2018; 14(13):1813-1821. PubMed ID: 30443185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
    Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y
    BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
    He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
    Front Immunol; 2022; 13():835630. PubMed ID: 35401554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
    Saal J; Bald T; Eckstein M; Ralser DJ; Brossart P; Ellinger J; Hölzel M; Klümper N
    Lung Cancer; 2024 Mar; 189():107505. PubMed ID: 38367405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio.
    Gao J; Ren Y; Guo H; Mao R; Xie H; Su H; She Y; Deng J; Yang M; Han B; Zhang Y; Li J; Xie D; Chen C
    Ann Transl Med; 2020 Apr; 8(7):470. PubMed ID: 32395514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer.
    Minami S; Ogata Y; Ihara S; Yamamoto S; Komuta K
    Lung Cancer (Auckl); 2017; 8():249-257. PubMed ID: 29263709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.